Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

54
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
54
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Academic Engagement and Contextual Factors Associated with Academic Performance in First-Year Medical Students: A Cross-Sectional Study.

Advances in medical education and practice·2026
Same author

The Pterygopalatine Ganglion Within the Pterygopalatine Fossa: Quantitative Topography and Implications for Posteriorly Directed Percutaneous Access.

Clinical anatomy (New York, N.Y.)·2026
Same author

Time course of early and delayed myocardial protection induced by vagal nerve stimulation preconditioning.

Basic research in cardiology·2026
Same author

Angiotensin II type 2 receptor activation alleviates inflammation and oxidative stress caused by chronic exposure to air pollution.

Environmental toxicology and pharmacology·2025
Same author

<i>N</i>-Acetylcysteine Treatment Restores the Protective Effect of Heart Ischemic Postconditioning in a Murine Model in the Early Stages of Atherosclerosis.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model.

Antioxidants (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 2, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K

Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Bruno Buchholz1, Martín Donato, Verónica D'Annunzio

  • 1Department of Pathology, School of Medicine, Institute of Cardiovascular Physiopathology, University of Buenos Aires, JE Uriburu 950 - 2nd Floor, C1114AAD, Buenos Aires, Argentina.

Molecular and Cellular Biochemistry
|March 14, 2014
PubMed
Summary

Ischemic postconditioning, brief reperfusion episodes, reduces heart attack damage. Pharmacological agents mimicking this effect show promise for treating ischemic heart disease (IHD).

More Related Videos

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.0K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.2K

Related Experiment Videos

Last Updated: May 2, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.0K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.2K

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Translational Medicine

Background:

  • Ischemic heart disease (IHD) is a leading cause of mortality and heart failure.
  • Acute myocardial infarction (heart attack) necessitates novel therapeutic strategies.
  • Ischemic postconditioning, brief ischemia/reperfusion at reperfusion onset, reduces infarct size.

Purpose of the Study:

  • To review the mechanisms of ischemic postconditioning.
  • To discuss the role of autacoids, cytokines, and signaling pathways.
  • To evaluate the clinical applicability of ischemic postconditioning in IHD.

Main Methods:

  • Review of existing research on ischemic postconditioning mechanisms.
  • Analysis of autacoid and cytokine involvement (e.g., adenosine, bradykinin, opioids).
  • Exploration of kinase signaling pathways and mitochondrial modulation.

Main Results:

  • Ischemic postconditioning involves complex signaling pathways and mediators.
  • Pharmacological agents can mimic cardioprotective effects of ischemic postconditioning.
  • Comorbidities may influence the efficacy of postconditioning strategies.

Conclusions:

  • Ischemic postconditioning and pharmacological mimics offer potential therapeutic avenues for IHD.
  • Further large-scale, randomized clinical trials are essential.
  • Determining the clinical benefit for IHD patients requires rigorous evaluation.